MTA-K

GOAL

То improve the outcomes of transplant recipients.

FUNCTION

То facilitate innovative clinical and translational research in solid organ transplant recipients through partnership between like-minded clinical centers, researchers, industry, and funding agencies.

ADVANTAGES

The major advantage of having а group like ours is that clinical studies саn bе performed with greater efficiency, quality, and innovation.

  1. lnfrastructure for “one-stop shopping” including contracting, protocol development, uniform data collection, etc. А major goal is to decrease the time from concept to initiation.
  2. Collaborative centers – streamlined enrollment, decrease time to completion of the studies.
  3. AII programs perform similar detailed follow-up as рагt of standard of саге.
  4. Biobank of allograft tissue and serum.
  5. Staff with time dedicated to these activities.

MTA-K SITES

Mayo Clinic - Rochester, MN University of MichiganAnn Arbor, MI Henry Ford HospitalDetroit, MI Cornell University New York, NY University of Pittsburg Pittsburg, PA Terasaki Research InstituteLos Angeles, CA Mayo ClinicScottsdale, AZ East Carolina University Greenville, NC Wake Forest Baptist Health Winston-Salem, NC Mayo ClinicJacksonville, FL

Mayo Clinic - Rochester, MN
Coordinating Team Members

  • Mark D. Stegall, M.D.
  • Mollie J. Luhman (team coordinator)
  • Carrie A. Schinstock, M.D
  • Hatem Amer, M.D.
  • Andrew J. Bentall, M.B., Ch.B.
  • Byron H. Smith, Ph.D.
  • Walter D. Park
  • Nong Y. Braaten
  • Leah M. Majerus

University of Michigan - Ann Arbor, MI
Coordinating Team Members

  • Randall S. Sung, M.D.

Henry Ford Hospital - Detroit, MI
Coordinating Team Members

  • Dean Kim, M.D.

Cornell University - New York, NY
Coordinating Team Members

  • Darshana M. Dadhani, M.D.

University of Pittsburg - Pittsburg, PA
Coordinating Team Members

  • Sundaram Hariharan, M.D.
  • Fadi Lakkis, M.D.

Terasaki Research Institute - Los Angeles, CA
Coordinating Team Members

  • Matthew Everly, PharmD, BCPS, FAST

Mayo Clinic - Scottsdale, AZ
Coordinating Team Members

  • Raymond Heilman, M.D.
  • Harini Chakkera, M.D.
  • Kunam Reddy, M.B.B.S

East Carolina University- Greenville, NC
Coordinating Team Members

  • David B. Leeser, M.D.

Wake Forest Baptist Health- Winston Salem, NC
Coordinating Team Members

  • Colleen L. Jay, M.D.

Mayo Clinic - Jacksonville, FL
Coordinating Team Members

  • Martin Mai, M.D.
  • Dana Perry, M.D.

Current Multicenter Studies

NIH UO1 AI 96326 Using intragraft gene expression to predict subsequent decline in renal function (MCR, MCA, MCF, Henry Ford) – PI: Mark Stegall, M.D. (MCR)

Retrospective study of de novo DSA (MCR, MCA, Cornell, University of Michigan)

Areas of Interest

  1. Renal transplantation and the development of intervention trials.
  2. Development of a multicenter data warehouse for all types of studies, both prospective and retrospective.
  3. MTA will have both the breadth of data currently only available in large registries and detailed data currently only found in single centers.

Primary contact:

Mollie Luhman

Program Coordinator

507-266-2812

luhman.mollie@mayo.edu